Please ensure Javascript is enabled for purposes of website accessibility
CASE REPORT
Large abscesses on the border of segment VII and VIII of the liver treated effectively pharmacologically – empirically chosen antibiotic therapy for a patient with diabetes
 
More details
Hide details
 
Submission date: 2015-02-01
 
 
Final revision date: 2015-05-19
 
 
Acceptance date: 2015-08-05
 
 
Publication date: 2015-10-23
 
 
Medical Studies 2015;31(3):203-206
 
KEYWORDS
TOPICS
ABSTRACT
Liver abscesses are focal necroinflammatory lesions of bacterial, fungal, or amoebic origin. Pharmacological treatment is rarely sufficient if negative blood cultures are present. The report presents the case of a 62-year-old man with hypertension and type 2 diabetes, diagnosed with liver abscesses. The patient received two-stage empirical antibiotic therapy. Firstly in the hospital setting – cefuroxym, gentamicin, and metronidazole. After a 10-fold reduction in C-reactive protein and clinical improvement the patient was discharged home. In the second stage – ceftibutyn, metronidazole, and fluconasol were used in the outpatient setting. During rehospitalisation, a significant reduction in the size of abscesses was noted. The patient was twice consulted bacteriologically (treatment was accepted) and his computed tomography (CT) scans were sent for surgical consultation, which confirmed the effectiveness of the drug treatment and did not qualify for surgical treatment. In the 8-month follow-up there was no relapse and CT scans showed only scarring of the liver.
REFERENCES (14)
1.
Krawczyk M. Wątroba. In: Chirurgia. Noszczyk W (ed.). Wydawnictwo Lekarskie PZWL, Warsaw 2007; 782-820.
 
2.
Alkofer B, Dufay C, Parienti JJ, et al. Are pyogenic liver abscesses still a surgical concern? A western experience. HPB Surg 2012, Article ID 316013.
 
3.
Wang CL, Guo XJ, Qiu SB, et al. Diagnosis of bacterial hepatic abscess by CT. Hepatobiliary Pancreat Dis Int 2007; 6: 271-5.
 
4.
Rajender Reddy K. Bacterial, parasitic, fungal, and granulomatous liver disease. In: Goldman’s Cecil Medicine. Goldman L, Schafer AI (eds.). Elsevier, Philadelphia 2012; 987-96.
 
5.
Ali T. Absces, liver. In: Ferri’s Clinical Advisor 2015. Ferri FF (ed.). Elsevier, Philadelphia 2015; 12-3.
 
6.
Yu SC, Ho SS, Lau WY, et al. Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Hepatology 2004; 39: 932-8.
 
7.
Chan DSG, Archuleta S, Llorin RM, et al. Standardized outpatient management of Klebsiella pneumoniae liver abscesses. Int J Infect Dis 2013; 17: 185-8.
 
8.
Tian LT, Yao K, Zhang XY, et al. Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clin Microbiol Infect 2012; 18: 314-30.
 
9.
Balck SM, Prabhakaran S, Vickers SM. Liver abscess. In: Shackelford’s Surgery of the Alimentary Tract. Yeo ChJ (ed.). Elsevier, Philadelphia 2013; 1464-78.
 
10.
Herrera JL, Knudsen CD. Liver abscess. GI/Liver Secrets Plus, 2015; 237-42.
 
11.
Kasiukiewicz A, Wojszel ZB. Infective endocarditis – clinical presentation and therapy in older people. Postępy Nauk Medycznych 2011; 8: 658-65.
 
12.
Mocchegiani R, Nataloni M. Complications of infective endocarditis. Cardiovasc Hematol Disord Drug Targets 2009; 9: 240-8.
 
13.
Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis and treatment of infective endocarditis of the ESC. Eur Heart J 2009; 30: 2369-413.
 
14.
Kraśnicka-Sokół B, Kochmański M, Filczak K. Prognostic useful of the new risk index for infective endocarditis. Pol Merkur Lekarski 2008 24: 484-6.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top